Purchase Order 75N95023P00860
Award Date
9/25/23
Potential Completion Date
11/25/23
Potential Value
$72K
Federal Agency
National Institute on Drug Abuse
Awardee
Agilent Technologies Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Santa Clara, CA 95051, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $7,498.00 Firm Fixed Price Purchase Order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of the Agilent Technologies, Inc. parent company. This award is for the delivery of a "CUSTOM 0.5-2.9MB LIBRARY SUFFICIENT FOR POST-CAPTURE PROCESSING OF 16 SAMPLES", with a completion date of September 20, 2017. The contract...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $701,584. The contract calls for the synthesis of 13,492 antisense oligonucleotides in support of an ongoing SARS-CoV-2 study for the NIH National Institute on Drug Abuse. As the incumbent contractor, Integrated DNA Technologies previously synthesized the oligonucleotides...
This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $28,510.03. Under the terms of the contract, IDT will provide custom synthesis, purification, normalization, and delivery of nine antisense oligonucleotides to the National Institute on Drug Abuse by August 15, 2023. The ASOs will support neurotoxicity studies evaluating a potential platform for predicting adverse effects of...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $50,352 fixed price purchase order contract to Agilent Technologies Inc. for the delivery of biological products in support of genomic research efforts. The contract calls for Agilent to provide four units of SureSelect Custom 1Kb-499kb capture kits, two kits of SSEL XT Low Input Reagent kits containing reagents for 1-96 samples, and two kits with reagents for 97-192 samples. All products are to...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $95,768.60 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide 12 units of its Infinium Global Diversity Array-8 v1.0 kit with 96 samples per unit and 1 unit with 48 samples to support the agency's biomedical research efforts. Performance will take place in San Diego through August 2024. No set aside...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,000.00 firm-fixed-price purchase order to ChemDiv, Inc. to provide a compound library of 8,000 specific and unique small molecule compounds. The compounds are being procured for the National Center for Advancing Translational Sciences (NCATS) to support their Genesis screening library. The contract does not have a set-aside designation, and the place of performance is San...
This non-competitive contract award from the National Institutes of Health's National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. is for $20,026.50 to provide custom synthesis of nine antisense oligonucleotides for a neurotoxicology study. Per the solicitation, IDT will synthesize the oligos using proprietary machines and deliver the highest accuracy in sequence. They will also offer design support and expertise. The period of performance is August 7-21,...
The National Institutes of Health's National Institute on Drug Abuse awarded a $6.5 million firm fixed price delivery order to Illumina, Inc. of San Diego, California. The order is for NOVASEQ 6000 S4 reagents kits to support library preparation and whole genome sequencing as part of NIH/NIDA's ongoing biomedical research efforts. Performance will take place in San Diego through June 2021. Illumina will provide the requested next-generation sequencing products and services as the prime...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $77,874 purchase order to Twist Bioscience Corporation of South San Francisco, California. Under the firm fixed price contract, Twist Bioscience will provide custom cloned pooled oligo libraries in support of the NIH NIA's biomedical research efforts. The contract runs from July 10, 2023 through August 31, 2023 and represents a small purchase awarded directly to the prime contractor...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed-price purchase order valued at $406,293.14 to Life Technologies Corporation for a DNA analyzer. The solicitation sought quotes for a device to be used by NIH's National Institute on Drug Abuse that provides microsatellite-based fragment analysis, de novo sequencing, resequencing, and single-nucleotide polymorphism genotyping analysis while processing multiple DNA samples...